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Hyperbilirubinemia is toxic to the auditory pathways 
and to the central nervous system, leaving sequelae such 
as hearing loss and encephalopathy. Aim: to assess the 
hearing of neonates with hyperbilirubinemia, using transient 
evoked otoacoustic emissions (TOAEs) and brainstem evoked 
auditory potentials (BEAP). Prospective study. Materials 
and Methods: we had two groups: GI (n-25), neonates 
with hyperbilirubinemia; GII (n-22), neonates without 
hyperbilirubinemia and without risk factors for hearing loss. 
All the neonates had up to 60 days of life and were submitted 
to TOAE and BEAP. Results: 12 neonates from GI and 10 
from GII were girls and 13 from GI and 12 from GII were 
boys. TOAEs were present in all the children, however with 
lower amplitudes in GI, especially in the frequencies of 2 
and 3KHz (p < 0.05). Regarding the BEAP, we observed a 
mild PV and LI-V increase in BI. The alterations observed in 
these tests do not correlate to the serum levels of bilirubin. 
Conclusions: in neonates with hyperbilirubinemia, we 
noticed lower TOAE amplitudes and mild PV and LI-V 
increase, indicating cochlear and retrocochlear disorders, 
stressing the importance of using both tests and carefully 
reading them in these evaluations.
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INTRODUCTION
Hearing is responsible for the development of 
spoken language, which requires an intact peripheral and 
central auditory system. Many factors may affect hearing 
during the neonatal period, including hyperbilirubinemia, 
which manifests clinically as jaundice.
Jaundice is defined as a yellowish skin color due 
to increased bilirubin levels in extracellular fluids. It is 
considered physiological when increased non-conjugated 
bilirubin levels occur within the first two weeks of life. 
Pathological cases that cause concern present elevated 
levels of this pigment within the first 24 hours of life; early 
treatment is required, whether phototherapy or exchange 
transfusion.1,2
Many authors have highlighted the harmful effects 
of biliary pigment impregnation of central and periphe-
ral auditory pathways.3-5 Hyperbilirubinemia is toxic for 
endocochlear hair cells, basal nuclei and central auditory 
pathways.4 The intensity of hearing loss may vary and it 
may or may not be reversible. An early diagnosis - within 
the first months of life - is mandatory. Testing of otoa-
coustic emissions (OAE) and brainstem auditory evoked 
potentials (BAEP) stand out among the diagnostic methods 
due to their objectivity and reliability. OAE assess cochlear 
function, specifically that of the outer hair cells (preneural 
pathways), and are used in assessing cochlear diseases, 
such as exposure to ototoxic substances, viruses, and 
noise; it is also applied in neonatal auditory screening.6-8 
BAEP record the electrophysiological activity of the peri-
pheral auditory system up to the brainstem, which arises 
within the first 10-12 ms following sound stimulation; 
retrocochlear pathways may thus be studied.9
In neonates with hyperbilirubinemia, evoked OAE 
(EOAE) may or may not yield responses; the latter indi-
cates cochlear damage. BAEP may detect an increased 
electrophysiological threshold, absence of responses, and 
prolonged wave and interpeak absolute latencies; these 
changes may or may not be reversible with therapy. Ac-
cording to some authors, therapeutic success is related 
with serum bilirubin levels.4,10-12 On the other hand, other 
authors have not demonstrated altered auditory pathways 
in neonates with hyperbilirubinemia, such as in _gun et 
al.’s13 study of 30 newborns aged from 24 to 72 months, 
who were screened with BAEP, transient-evoked OAE 
(TEOAE) and a speech-language questionnaire. OAE and 
electrophysiological potentials recorded at 80 dB were 
present in all children, who also had normal language 
development. These authors found no correlation among 
total serum bilirubin levels and altered BAEP thresholds 
and latencies.
These contradictory results justify new studies 
to assess auditory pathway integrity in neonates with 
hyperbilirubinemia to establish the degree of harm and 
the sectors affected.
SERIES AND METHOD
Series
Two study groups were defined: a study or sample 
group (GI) consisting of 25 neonates with hyperbilirubi-
nemia, confirmed as serum indirect bilirubin levels above 
3 mg/dL, and undergoing phototherapy and/or exchange 
transfusion; a control group (GII) composed of 22 neonates 
with serum indirect bilirubin levels below 3 mg/dL and 
no risk factors for hearing loss. All control group neonates 
underwent the same sequence of auditory assessments as 
the study group.
The caretakers of candidates for the study and 
control groups signed a free informed consent form. The 
Research Ethics Committee of the institution in which 
research was conducted approved the study (protocol 
271/2007).
The following exclusion criteria were defined for 
standardization purposes: a family history of hearing loss 
(including reports of inherited or genetic deafness); use 
of ototoxic drugs by mothers during pregnancy or by 
neonates; presence of cranio-facial malformations; altered 
otoscopy; neonatal hypoxia (assessed as Apgar values be-
low 4 in the first minute and 6 in the fifth minute); aged 
above three months.
METHOD
Initially, parents were interviewed to fill in the 
study protocol and to gather a clinical history. A review 
was made of medical files in search of data on: age, sex, 
intercurrences during pregnancy, birth status, blood type of 
the mother and of the newborn, serum direct and indirect 
bilirubin levels; and type of therapy (phototherapy and/
or exchange transfusion).
Auditory assessment - prior to an evaluation of 
hearing, all neonates underwent meatoscopy, which was 
carried out by an otorhinolaryngologist using a battery-
operated Heyne otoscope (Germany).
Audiological studies consisted of TEOAE and BAEP 
testing. TEOAE were tested with non-linear clicks, in an 
acoustic booth using a cochlear emissions analyzer (ILO 
288, Otodynamic Ltda) coupled to a microcomputer. The 
Quickscreener software, indicated for auditory screening, 
was used in the procedure. Responses were recorded at 
frequency bands of 1.0, 1.5, 2.0, 3.0 and 4.0 Hz within a 
12 ms window. The following analytical parameters were 
used for interpreting the results: probe stability above 70%, 
stimulus intensity from 79 to 83 dB, signal reproducibility 
over 70%, and response amplitude equal to or above 6 
dBSPL over the noise spectrum in three consecutive fre-
quencies.
BAEP testing was done using an EP-15 device 
(Eclipse, Interacoustics, Denmark) in a silent room. After 
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skin cleaning with an abrasive substance, positive or active 
surface electrodes (Neuroline) were placed on the forehe-
ad, and negative or reference electrodes were placed on 
the mastoid area. The ground electrode was placed on the 
forehead. Monaural stimuli (80 dBSPL rarefied polarity 100 
ms filtered clicks from 100 to 3,000 Hz) were presented 
through insertion earphones (ER 3A). There were 1,024 
clicks with a 15 ms analysis time, repeated to confirm 
wave reproduction. The electrode impedance was always 
below 5 KOhms. The stimulus frequency was 20.1 clicks 
per second.
Pearson’s correlation coefficient was applied in 
the statistical analysis for measuring associations among 
variables;14 the significance level was 5%. Statistically 
significant results are marked (*) in the Tables.
RESULTS
• Age range
11 neonates in GI (44%) and 13 neonates in GII 
(59%) were aged at least one month; 14 neonates in GI 
(56%) and nine neonates in GII (41%) were aged two 
months.
• Sex
There were no sex differences between groups; 
there were 12 female neonates in GI (48%) and 10 female 
neonates in GII (45.50%); there were 13 male neonates in 
GI (52%) and 12 male neonates in GII (54.50%).
• Results of TEOAE responses per frequency band 
- 2K, 3K and 4KHz - in ears tested in both groups
Figures 1 and 2 show increased response amplitudes 
as the frequency increases in both groups. Amplitudes in 
GI were lower than in GII, which was statistically signifi-
cant at 2 and 3KHz (p < 0.05).
undergone repeated phototherapy sessions. OAE ampli-
tude values, especially in these seven children, were not 
the lowest recorded values, which made it impossible to 
establish a causal relation among variables.
• BAEP results in ears tested in both groups
PI and PIII values were similar in both groups. 
Right ear PV was discretely prolonged in GI (Table 1; p < 
0.05) as was LI-V; other interpeaks showed no differences 
(Table 2; p < 0.05). These recorded BAEP alterations in GI 
neonates were not matched with the seven children that 
had the highest serum bilirubin levels.
Figure 1. Response amplitude at 2K, 3K and 4KHz frequency ranges 
in transient otoacoustic emissions testing in the right ear in both study 
groups.
Seven neonates in GI had serum unconjugated 
bilirubin levels over 15mg/dL; four of these neonates had 
undergone exchange transfusion, and three neonates had 
Figure 2. Response amplitude at 2K, 3K and 4KHz frequency ranges 
in transient otoacoustic emissions testing in the left ear in both study 
groups.
Table 1. Mean and standard deviation of absolute latencies of waves 
PI, PIII and PV in each study group (in ms)
Group Ear Wave
I III V
GI RE
1,40 ± 
0,09
4,13 ± 
0,24
6,31 ± 
0,26 *
LE
1,42 ± 
0,09 
4,14 ± 
0,25
6,29 ± 
0,26 
GII RE
1,41 ± 
0,11
4,02 ± 
0,10 
6,17 ± 
0,16 
LE
1,40 ± 
0,10
4,04 ± 
0,12 
6,22 ± 
0,18
Table 2. Mean and standard deviation of interpeak latencies LI - III, 
LIII - V and LI - V in each study group (in ms).
Group Ear Interpeaks
I - III III - V I - V
GI RE
2,72 ± 
0,23
2,18 ± 
0,17
4,90 ± 
0,26 *
LE
2,72 ± 
0,23 
2,14 ± 
0,18
4,87 ± 
0,26 
GII RE
2,60 ± 
0,13
2,15 ± 
0,15 
4,76 ± 
0,20 
LE
2,64 ± 
0,16
2,17 ± 
0,14 
4,81 ± 
0,21
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DISCUSSION
Elevated serum levels of unconjugated bilirubin 
are considered toxic for the auditory pathways and the 
central nervous system, and are included among the risk 
factors for neonatal deafness and encephalopathies. A 
high concentration of biliary pigments is treated with 
phototherapy and/or exchange transfusion; the latter is 
reserved for severe cases and those resistant to repeated 
phototherapy.1,2
TEOAE have been widely applied in the assessment 
of hearing in neonates; it is the test of choice for neonatal 
auditory screening.3,6,15,16 In this study, emissions were 
found in all neonates of both groups; however, control 
group (GII) neonates had higher recorded amplitude va-
lues compared to GI neonates, especially at 2 to 3 KHz. 
This finding suggests possible endocochlear involvement 
due to the toxic effect of biliary pigments. Rapid pass-fail 
type auditory screening methods used at many centers 
may miss subtle changes in response amplitudes. Some 
authors have underlined the importance of analyzing 
TEOAE amplitudes when comparing term and preterm 
neonate responses. Amplitudes may be decreased in ne-
onates at any risk for hearing loss, such as in premature 
birth.17 This alteration was encountered in this study, es-
pecially in GI neonates, even those with mildly elevated 
serum biliary pigment. A review of the literature found 
no studies that analyzed OAE amplitudes in children with 
hyperbilirubinemia.
It is therefore clear that results should not be inter-
preted based only on present or absent responses in the 
auditory evaluation of neonates, but rather on features of 
the recordings. Minor amplitude variations in OAE may 
be diagnosed, even when using only TEOAE. However, 
analyses of distortion product OAE increase the reliabi-
lity of the method, making it possible to track a wider 
frequency range.
Martinho & Lewis5 and Oysu et al.18 found TEOAE 
with strong amplitudes in severe hyperbilirubinemia cases; 
altered BAEP recordings, however, suggested auditory 
neuropathy.
The results of the present study showed that higher 
serum bilirubin levels did not alter TOAE amplitude values 
or BAEP electrophysiological potential latencies. Some 
authors, however, have presented a cause-effect relation 
between these variables, as shown by Lenhardt et al.19 
These authors performed BAEP testing in 10 neonates with 
hyperbilirubinemia soon after birth and repeated the test 
in five of these children. They compared the results with 
a control group consisting of 10 neonates with normal 
serum bilirubin levels, and found that absolute PIII and 
PV latencies were higher in the study group, compared 
with the control group; these values relate directly with 
increased serum bilirubin concentrations.
The reversibility of auditory pathway damage follo-
wing the treatment of hyperbilirubinemia could not be 
established in this study due to delays in referring these 
children. However, auditory pathway alterations were 
recorded at two months post-therapy, which suggested 
temporary or permanent auditory sequelae. Thus it is 
important to follow up these children on an ambulatory 
basis, monitoring not only language, but also cognitive 
development. Wemberg et al.20 reported a case of a neo-
nate with hyperbilirubinemia due to Rh incompatibility, in 
whom BAEP testing was done within 27 hours of life; these 
authors found that when the serum bilirubin concentration 
was higher than 15 mg/dL, elevated electrophysiological 
thresholds and prolonged PV were recorded. The authors 
repeated BAEP testing after exchange transfusion done 
at 36 hours of life, and found that electrophysiological 
thresholds improved, but PV latency remained altered. At 
three months follow-up, electrophysiological thresholds 
gradually returned to normal values; however, the LI-V 
interval remained prolonged, which suggested retrococh-
lear auditory sequelae.
Nwaesei et al.21 also highlighted the reversible na-
ture of auditory alterations after exchange transfusion in a 
study of nine neonates that were transfused; BAEP testing 
was done one hour before and one hour after exchange 
transfusion.
Nakamura et al.22 carried out BAEP testing in audi-
tory assessments of 56 hyperbilirubinemic neonates and 
24 neonates with no jaundice to verify whether bilirubin 
could cause early ototoxicity. Absolute PI latencies were 
increased compared with the control group. These authors 
also found that isolated wave latencies improved after 
exchange transfusion, where PI recovered before PV, al-
though the interpeak LI-V latency did not improve.
Sharma et al.23 carried out BAEP testing for the audi-
tory assessment of 30 jaundiced neonates soon after birth 
and after 2 to 4 months. The mean wave absolute latencies 
and their interpeaks were prolonged in jaundiced neonates 
compared with controls, suggesting early bilirubin-induced 
encephalopathy. BAEP alterations persisted in 23.3% of 
these cases in follow up, demonstrating the importance 
of this test for early detection of hearing loss.
Long-term follow-up results on auditory pathway 
integrity vary among authors. Some authors raise the possi-
bility of auditory sequelae even with early and appropriate 
therapy. Sabatino et al.24 applied BAEP testing in the third 
day of life in 48 term neonates with elevated serum total 
bilirubin, and repeated the evaluation on the fifth or seven-
th day after therapy. Supplemental retest recordings were 
made at three, six and 12 months. The first assessments 
showed a statistically significant prolonged PIII and PV 
compared with controls, which improved in subsequent 
evaluations. Neuropsychological assessments across three 
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years were normal, suggesting that altered auditory nerve 
central neurotransmission may be temporary and isolated, 
without affecting cognition.
Yilmaz et al.25 carried out BAEP testing in 22 neo-
nates with hyperbilirubinemia up to age 12 months and 
found that two neonates had altered BAEP that suggested 
auditory neuropathy; this led to delays in language acqui-
sition but no other neurological development alterations. 
On the other hand, two other subjects had neurological 
sequelae but normal BAEP results. It thus appears that 
neurological sequelae due to biliary pigment impregnation 
are selective.
Rhee et al.10 assessed auditory acuity following 
exchange transfusion in 11 neonates with severe hyperbili-
rubinemia, applying BAEP, TEOAE and immittance testing 
in their evaluation. These authors found normal immittance 
and TOAE recordings, but did not undertake a careful 
analysis of amplitudes at each frequency. In BAEP testing, 
electrophysiological thresholds were normal in seven neo-
nates, high in one neonate and absent at 90 dBSPL in three 
neonates. Subsequent evaluations one year later revealed 
that electrophysiological thresholds improved considera-
bly. BAEP alterations in these children with normal OAE 
test were interpreted as isolated retrocochlear damage with 
intact cochlear structures. One should be wary of such a 
conclusion, since detailed analyses of recorded emission 
amplitudes were not made in both groups.
Results of the present study underline the impor-
tance of OAE testing and auditory evoked potentials in 
the auditory evaluation of neonates, given that each of 
these tests assesses different sound stimulus transmission 
sites. Recordings should be analyzed quantitatively and 
in detail.
CONCLUSION
Lower amplitudes in TOAE recordings and discre-
tely prolonged PV and PI-V were found in the group of 
children with hyperbilirubinemia, suggesting that cochlear 
and retrocochlear auditory pathways may be affected. The 
importance of OAE and BAEP testing in these assessments 
and a careful quantitative and qualitative analysis of re-
cordings is highlighted.
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